EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Twenty Years of Benzimidazole Scaffold Optimization in Antiparasitic Drug Discovery

Martin Kondža iD, Valentina Rezić iD, Doris Drmač

ChemMedChem · 2026

DOI: 10.1002/cmdc.70426 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemMedChem, 2026. Verfasst von Martin Kondža und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, University of Mostar, Mostar, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Benzimidazoles, Drug Discovery, Antiparasitic Agents. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The benzimidazole scaffold occupies a unique position in antiparasitic medicinal chemistry: simple in structure yet extraordinarily versatile in biological action. Over the 20 years since ChemMedChem was established, substituted benzimidazoles have been among the most intensively optimized heterocyclic platforms for treating helminthiasis, malaria, leishmaniasis, and trypanosomiasis. This review surveys structure–activity relationship (SAR) studies published between 2005 and 2025, covering anthelmintic derivatives targeting β‐tubulin in nematodes, cestodes, and trematodes, as well as antiprotozoal scaffolds directed against Plasmodium , Leishmania , and Trypanosoma . We examine how substitutions at N‐1, C‐2, C‐5, and C‐6 modulate target affinity, selectivity, and pharmacokinetic properties, and discuss how growing benzimidazole drug resistance has driven structural innovation. Newly uncovered mechanisms of action, including inhibition of Leishmania mexicana arginase, pteridine reductase, Trypanosoma cruzi cruzain, and Plasmodium falciparum dihydroorotate dehydrogenase, are highlighted alongside classical tubulin‐directed SAR. The review also covers formulation advances and future directions including hybrid molecule design, in silico methods, and repurposing strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzimidazolesDrug DiscoveryAntiparasitic AgentsStructure-Activity RelationshipAnimalsHumansMolecular StructureDihydroorotate Dehydrogenase

Stichwörter der Autor:innen

antiparasitic agentsbenzimidazoledrug resistanceneglected tropical diseasesstructure–activity relationships

Substanzen

BenzimidazolesAntiparasitic AgentsbenzimidazoleDihydroorotate Dehydrogenase

Autor:innen und Institutionen

  • Faculty of Pharmacy, University of Mostar, Mostar, Bosnia and Herzegovina.

ORCID-Profile: Martin Kondža, Valentina Rezić

Zitieren

APA

Kondža, M., Rezić, V., & Drmač, D. (2026). Twenty Years of Benzimidazole Scaffold Optimization in Antiparasitic Drug Discovery. ChemMedChem. https://doi.org/10.1002/cmdc.70426

Vancouver

Kondža M, Rezić V, Drmač D. Twenty Years of Benzimidazole Scaffold Optimization in Antiparasitic Drug Discovery. ChemMedChem. 2026. doi:10.1002/cmdc.70426

BibTeX
@article{Konda2026,
  author = {Kondža, Martin and Rezić, Valentina and Drmač, Doris},
  title = {Twenty Years of Benzimidazole Scaffold Optimization in Antiparasitic Drug Discovery},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70426}
}
Kostenlos starten →